News

Article

Study: Sore eyes a common symptom in COVID-19 patients

Ocular symptoms in COVID-19 patients may be more common than previously thought — with sore eyes a significant sign of disease.


In a study published by BMJ Open Ophthalmology, investigators sought to determine three objectives: whether ocular symptoms were different in chronic sufferers of anterior eye diseases; when the symptoms were experienced; and how long the symptoms lasted when compared to other COVID-19 patients.

Analysis
Results of an online questionnaire of self-reported data from 83 participants over the course of two months with confirmed diagnoses of COVID-19 sought to ascertain the type, frequency and duration of different disease symptoms.

Additionally, investigators compared anterior eye symptoms experienced by respondents before their diagnosis and during the COVID-19 state.

Results found the most reported symptoms to be dry eye (66%), fever (76%), fatigue (90%), and lose off smell/taste (70%).1

Further results found that participants reported a number of ocular symptoms indicative of viral conjunctivitis.

The most three common ocular symptoms included photophobia (18%), sores eyes (16%), and itchy eyes (17%). Of those, the presence of sore eyes was significantly higher in patients during their COVID-19 state (16%) versus their pre-COVID-19 state (5%).1


Data on these results of ocular symptoms before and during COVID-19 confirmed cases using the McNemar’s test for paired comparisons can be seen in Table 1.1


Participants also reported dry eye symptoms more frequently before (23%) rather than during their COVID-19 state (14%) — a change investigators found surprising. However, this was found to be lacking any statistical significance.

Similarly, symptoms reported by participants with an association to various types of conjunctivitis — including mucous discharge and gritty eyes linked to bacterial infection — did not have significant results.

Investigators found that 81% of participants reported experiencing ocular symptoms within two weeks of other COVID-19 symptoms, and 80% reported the symptoms lasting less than two weeks.

Despite conjunctivitis being linked as a potential indicator of COVID-19, the study’s investigators concluded that “conjunctivitis” — a broad term — should be used with caution when in association of the disease.

References

1. Pardhan S, Vaughan M, Zhang J, et al. Sore eyes as the most significant ocular symptom experienced by people with COVID-19: a comparison between pre-COVID-19 and during COVID-19 states. BMJ Open Ophthalmology 2020;5:e000632. doi: 10.1136/bmjophth-2020-000632

Related Videos
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
(Image credit: Ophthalmology Times) AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhD
© 2025 MJH Life Sciences

All rights reserved.